My perspective now is that the new funding scenario that will occur will only add about 20% to 30% additional dilution ( compared to the scenario with funding from the unlisted oppies and for that we probably still needed additional funds, perhaps from debt ).
I'm also relaxed about the situation. Disappointed but relaxed. Once the funding arrangements are confirmed and in place in Q3, we will be one of the lowest risk transitioning smallcaps on the ASX. 2-3 bags will get our market CAP into the $150M to $200M range within 20 months. There will be staged growth from there.
Enjoy the adventure. Will be fun to watch it play out.
BAT Price at posting:
6.2¢ Sentiment: Buy Disclosure: Held